Federica Mezzasoma

4PUBLICATIONS
30CO-AUTHORS
Molecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 04, 2024
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML.

Matteo Marchesini, Andrea Gherli, Elisa Simoncini

|Aug 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML.

Giulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma

|Aug 03, 2021
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.

Maria Paola Martelli, Roberta Rossi, Alessandra Venanzi

|Feb 02, 2021
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells.

Vincenzo Maria Perriello, Ilaria Gionfriddo, Roberta Rossi

Pageof 1

Frequent Collaborators

3 joint publications

Lorenzo Brunetti

3 joint publications

Maria Paola Martelli

2 joint publications

Orietta Spinelli

2 joint publications

Alessandro Rambaldi